DewCell Overview
- Year Founded
-
2021
- Status
-
Private
- Employees
-
25
- Latest Deal Type
-
Series C
- Latest Deal Amount
-
$15.8M
- Investors
-
27
DewCell General Information
Description
Developer of a biotechnology company designed to create artificial platelets using human-derived stem cell-induced differentiation technology and biomimetic technology. The company's system secures differentiation technology from stem cells into megakaryocytes that generate platelets and mass-produces artificial platelets, providing medical researchers with platelets that can solve the shortage of blood-derived platelets.
Contact Information
Website
www.dewcell.comCorporate Office
- Building A, Room 307, 660 Daewangpangyo-ro
- Yuspeace 1, Bundang-gu
- Seongnam, Gyeonggi 13494
- South Korea
Corporate Office
- Building A, Room 307, 660 Daewangpangyo-ro
- Yuspeace 1, Bundang-gu
- Seongnam, Gyeonggi 13494
- South Korea
DewCell Timeline
DewCell Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 5. Later Stage VC (Series C) | 29-Mar-2026 | $15.8M | Completed | Generating Revenue | ||
| 4. Early Stage VC (Series B) | 28-Apr-2024 | Completed | Generating Revenue | |||
| 3. Early Stage VC (Series A) | 30-Jul-2022 | Completed | Generating Revenue | |||
| 2. Accelerator/Incubator | 03-Apr-2022 | $409K | $2.35M | Completed | Generating Revenue | |
| 1. Seed Round | 30-Nov-2021 | $1.94M | $1.94M | Completed | Generating Revenue |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
DewCell Patents
DewCell Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2024205363-A1 | Methods for producing red blood cells and platelets | Inactive | 29-Mar-2023 | ||
| WO-2024076030-A1 | Method for producing platelets | Inactive | 05-Oct-2022 |
DewCell Signals
DewCell Investors (27)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Evergreen Investment Partners | Venture Capital | Minority | ||
| Hanwha Investment & Securities Company | Asset Manager | Minority | ||
| Hyundai Investment Partners | Asset Manager | Minority | ||
| IBK Capital | Investment Bank | Minority | ||
| IBK Venture Investment | Corporate Venture Capital | Minority |
DewCell Investments (1)
DewCell’s most recent deal was a Corporate Asset Purchase with DewCell (Quasi-Good Manufacturing Practice Production Facility in Anyang, South Korea). The deal was made on 10-Feb-2026.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| DewCell (Quasi-Good Manufacturing Practice Production Facility in Anyang, South Korea) | 10-Feb-2026 | Corporate Asset Purchase | Buildings and Property |
DewCell FAQs
-
When was DewCell founded?
DewCell was founded in 2021.
-
Where is DewCell headquartered?
DewCell is headquartered in Seongnam, South Korea.
-
What is the size of DewCell?
DewCell has 25 total employees.
-
What industry is DewCell in?
DewCell’s primary industry is Biotechnology.
-
Is DewCell a private or public company?
DewCell is a Private company.
-
What is DewCell’s current revenue?
The current revenue for DewCell is .
-
How much funding has DewCell raised over time?
DewCell has raised $24.7M.
-
Who are DewCell’s investors?
Evergreen Investment Partners, Hanwha Investment & Securities Company, Hyundai Investment Partners, IBK Capital, and IBK Venture Investment are 5 of 27 investors who have invested in DewCell.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process